Peptic Ulcer Drugs Market in South Korea - Manufacturing and Consumption, Outlook and Forecast 2020-2026
A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies peptic ulcer drugs market.
This report contains market size and forecasts of Peptic Ulcer Drugs in South Korea, including the following market information:
South Korea Peptic Ulcer Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Peptic Ulcer Drugs Market Consumption, 2015-2020, 2021-2026, (M Unit)
South Korea Peptic Ulcer Drugs Production Capacity, 2015-2020, 2021-2026, (M Unit)
Top Five Competitors in South Korea Peptic Ulcer Drugs Market 2019 (%)
The global Peptic Ulcer Drugs market was valued at 16580 million in 2019 and is projected to reach US$ 19130 million by 2026, at a CAGR of 3.6% during the forecast period. While the Peptic Ulcer Drugs market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Peptic Ulcer Drugs production and consumption in South Korea
Total Market by Segment:
South Korea Peptic Ulcer Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Unit)
South Korea Peptic Ulcer Drugs Market Segment Percentages, By Type, 2019 (%)
South Korea Peptic Ulcer Drugs Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Peptic Ulcer Drugs Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Peptic Ulcer Drugs Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Peptic Ulcer Drugs Market Competitors Sales, by Players 2015-2020 (Estimated), (M Unit)
Total South Korea Peptic Ulcer Drugs Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Peptic Ulcer Drugs in South Korea, including the following market information:
South Korea Peptic Ulcer Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Peptic Ulcer Drugs Market Consumption, 2015-2020, 2021-2026, (M Unit)
South Korea Peptic Ulcer Drugs Production Capacity, 2015-2020, 2021-2026, (M Unit)
Top Five Competitors in South Korea Peptic Ulcer Drugs Market 2019 (%)
The global Peptic Ulcer Drugs market was valued at 16580 million in 2019 and is projected to reach US$ 19130 million by 2026, at a CAGR of 3.6% during the forecast period. While the Peptic Ulcer Drugs market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Peptic Ulcer Drugs production and consumption in South Korea
Total Market by Segment:
South Korea Peptic Ulcer Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Unit)
South Korea Peptic Ulcer Drugs Market Segment Percentages, By Type, 2019 (%)
- Proton Pump Inhibitors
- Antacids
- H2-Antagonists
- Others
- Proton pump inhibitors segment was estimated to account for a revenue share of 75.6% in 2019.
South Korea Peptic Ulcer Drugs Market Segment Percentages, By Application, 2019 (%)
- Hospital and Clinic
- Drugstore
- Hospital and clinic segment was estimated to account for a sales share of 75.7% in 2019.
The report also provides analysis of leading market participants including:
Total Peptic Ulcer Drugs Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Peptic Ulcer Drugs Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Peptic Ulcer Drugs Market Competitors Sales, by Players 2015-2020 (Estimated), (M Unit)
Total South Korea Peptic Ulcer Drugs Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Takeda Pharmaceutical
- AstraZeneca
- Pfizer
- Teva Pharmaceuticals
- EA Pharma
- ASK Pharm
- Luoxin Pharmaceutical
- Abbott Laboratories
- Yuhan Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Peptic Ulcer Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 South Korea Peptic Ulcer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: SOUTH KOREA PEPTIC ULCER DRUGS OVERALL MARKET SIZE
2.1 South Korea Peptic Ulcer Drugs Market Size: 2020 VS 2026
2.2 South Korea Peptic Ulcer Drugs Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Peptic Ulcer Drugs Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Peptic Ulcer Drugs Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Peptic Ulcer Drugs Companies Ranked by Revenue
3.3 South Korea Peptic Ulcer Drugs Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Peptic Ulcer Drugs Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Peptic Ulcer Drugs Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Peptic Ulcer Drugs Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Peptic Ulcer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptic Ulcer Drugs Players in South Korea
3.8.1 List of South Korea Tier 1 Peptic Ulcer Drugs Companies
3.8.2 List of South Korea Tier 2 and Tier 3 Peptic Ulcer Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - South Korea Peptic Ulcer Drugs Market Size Markets, 2020 & 2026
4.1.2 Proton Pump Inhibitors
4.1.3 Antacids
4.1.4 H2-Antagonists
4.1.5 Others
4.2 By Type - South Korea Peptic Ulcer Drugs Revenue & Forecasts
4.2.1 By Type - South Korea Peptic Ulcer Drugs Revenue, 2015-2020
4.2.2 By Type - South Korea Peptic Ulcer Drugs Revenue, 2021-2026
4.2.3 By Type - South Korea Peptic Ulcer Drugs Revenue Market Share, 2015-2026
4.3 By Type - South Korea Peptic Ulcer Drugs Sales & Forecasts
4.3.1 By Type - South Korea Peptic Ulcer Drugs Sales, 2015-2020
4.3.2 By Type - South Korea Peptic Ulcer Drugs Sales, 2021-2026
4.3.3 By Type - South Korea Peptic Ulcer Drugs Sales Market Share, 2015-2026
4.4 By Type - South Korea Peptic Ulcer Drugs Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - South Korea Peptic Ulcer Drugs Market Size, 2020 & 2026
5.1.2 Hospital and Clinic
5.1.3 Drugstore
5.2 By Application - South Korea Peptic Ulcer Drugs Revenue & Forecasts
5.2.1 By Application - South Korea Peptic Ulcer Drugs Revenue, 2015-2020
5.2.2 By Application - South Korea Peptic Ulcer Drugs Revenue, 2021-2026
5.2.3 By Application - South Korea Peptic Ulcer Drugs Revenue Market Share, 2015-2026
5.3 By Application - South Korea Peptic Ulcer Drugs Sales & Forecasts
5.3.1 By Application - South Korea Peptic Ulcer Drugs Sales, 2015-2020
5.3.2 By Application - South Korea Peptic Ulcer Drugs Sales, 2021-2026
5.3.3 By Application - South Korea Peptic Ulcer Drugs Sales Market Share, 2015-2026
5.4 By Application - South Korea Peptic Ulcer Drugs Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Corporate Summary
6.1.2 Takeda Pharmaceutical Business Overview
6.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.1.4 Takeda Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.1.5 Takeda Pharmaceutical Key News
6.2 AstraZeneca
6.2.1 AstraZeneca Corporate Summary
6.2.2 AstraZeneca Business Overview
6.2.3 AstraZeneca Peptic Ulcer Drugs Major Product Offerings
6.2.4 AstraZeneca Sales and Revenue in South Korea (2015-2020)
6.2.5 AstraZeneca Key News
6.3 Pfizer
6.3.1 Pfizer Corporate Summary
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Peptic Ulcer Drugs Major Product Offerings
6.3.4 Pfizer Sales and Revenue in South Korea (2015-2020)
6.3.5 Pfizer Key News
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Corporate Summary
6.4.2 Teva Pharmaceuticals Business Overview
6.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Major Product Offerings
6.4.4 Teva Pharmaceuticals Sales and Revenue in South Korea (2015-2020)
6.4.5 Teva Pharmaceuticals Key News
6.5 EA Pharma
6.5.1 EA Pharma Corporate Summary
6.5.2 EA Pharma Business Overview
6.5.3 EA Pharma Peptic Ulcer Drugs Major Product Offerings
6.5.4 EA Pharma Sales and Revenue in South Korea (2015-2020)
6.5.5 EA Pharma Key News
6.6 ASK Pharm
6.6.1 ASK Pharm Corporate Summary
6.6.2 ASK Pharm Business Overview
6.6.3 ASK Pharm Peptic Ulcer Drugs Major Product Offerings
6.6.4 ASK Pharm Sales and Revenue in South Korea (2015-2020)
6.6.5 ASK Pharm Key News
6.7 Luoxin Pharmaceutical
6.6.1 Luoxin Pharmaceutical Corporate Summary
6.6.2 Luoxin Pharmaceutical Business Overview
6.6.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.4.4 Luoxin Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.7.5 Luoxin Pharmaceutical Key News
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Corporate Summary
6.8.2 Abbott Laboratories Business Overview
6.8.3 Abbott Laboratories Peptic Ulcer Drugs Major Product Offerings
6.8.4 Abbott Laboratories Sales and Revenue in South Korea (2015-2020)
6.8.5 Abbott Laboratories Key News
6.9 Yuhan Pharmaceutical
6.9.1 Yuhan Pharmaceutical Corporate Summary
6.9.2 Yuhan Pharmaceutical Business Overview
6.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.9.4 Yuhan Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.9.5 Yuhan Pharmaceutical Key News
6.10 Daewoong Pharmaceutical
6.10.1 Daewoong Pharmaceutical Corporate Summary
6.10.2 Daewoong Pharmaceutical Business Overview
6.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.10.4 Daewoong Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.10.5 Daewoong Pharmaceutical Key News
7 PEPTIC ULCER DRUGS PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Peptic Ulcer Drugs Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
7.1.1 South Korea Peptic Ulcer Drugs Production Capacity, 2015-2026
7.1.2 South Korea Peptic Ulcer Drugs Production 2015-2026
7.1.3 South Korea Peptic Ulcer Drugs Production Value 2015-2026
7.2 Key Local Peptic Ulcer Drugs Manufacturers in South Korea
7.2.1 South Korea Key Local Peptic Ulcer Drugs Manufacturers Production Capacity
7.2.2 South Korea Key Local Peptic Ulcer Drugs Manufacturers Production
7.2.3 South Korea Key Local Peptic Ulcer Drugs Manufacturers Production Value
7.2.4 The Proportion of Peptic Ulcer Drugs Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Peptic Ulcer Drugs Export and Import in South Korea
7.3.1 South Korea Peptic Ulcer Drugs Export Market
7.3.2 South Korea Peptic Ulcer Drugs Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for South Korea Peptic Ulcer Drugs Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON PEPTIC ULCER DRUGS SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Peptic Ulcer Drugs Distributors and Sales Agents in South Korea
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Peptic Ulcer Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 South Korea Peptic Ulcer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: SOUTH KOREA PEPTIC ULCER DRUGS OVERALL MARKET SIZE
2.1 South Korea Peptic Ulcer Drugs Market Size: 2020 VS 2026
2.2 South Korea Peptic Ulcer Drugs Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Peptic Ulcer Drugs Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Peptic Ulcer Drugs Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Peptic Ulcer Drugs Companies Ranked by Revenue
3.3 South Korea Peptic Ulcer Drugs Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Peptic Ulcer Drugs Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Peptic Ulcer Drugs Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Peptic Ulcer Drugs Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Peptic Ulcer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptic Ulcer Drugs Players in South Korea
3.8.1 List of South Korea Tier 1 Peptic Ulcer Drugs Companies
3.8.2 List of South Korea Tier 2 and Tier 3 Peptic Ulcer Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - South Korea Peptic Ulcer Drugs Market Size Markets, 2020 & 2026
4.1.2 Proton Pump Inhibitors
4.1.3 Antacids
4.1.4 H2-Antagonists
4.1.5 Others
4.2 By Type - South Korea Peptic Ulcer Drugs Revenue & Forecasts
4.2.1 By Type - South Korea Peptic Ulcer Drugs Revenue, 2015-2020
4.2.2 By Type - South Korea Peptic Ulcer Drugs Revenue, 2021-2026
4.2.3 By Type - South Korea Peptic Ulcer Drugs Revenue Market Share, 2015-2026
4.3 By Type - South Korea Peptic Ulcer Drugs Sales & Forecasts
4.3.1 By Type - South Korea Peptic Ulcer Drugs Sales, 2015-2020
4.3.2 By Type - South Korea Peptic Ulcer Drugs Sales, 2021-2026
4.3.3 By Type - South Korea Peptic Ulcer Drugs Sales Market Share, 2015-2026
4.4 By Type - South Korea Peptic Ulcer Drugs Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - South Korea Peptic Ulcer Drugs Market Size, 2020 & 2026
5.1.2 Hospital and Clinic
5.1.3 Drugstore
5.2 By Application - South Korea Peptic Ulcer Drugs Revenue & Forecasts
5.2.1 By Application - South Korea Peptic Ulcer Drugs Revenue, 2015-2020
5.2.2 By Application - South Korea Peptic Ulcer Drugs Revenue, 2021-2026
5.2.3 By Application - South Korea Peptic Ulcer Drugs Revenue Market Share, 2015-2026
5.3 By Application - South Korea Peptic Ulcer Drugs Sales & Forecasts
5.3.1 By Application - South Korea Peptic Ulcer Drugs Sales, 2015-2020
5.3.2 By Application - South Korea Peptic Ulcer Drugs Sales, 2021-2026
5.3.3 By Application - South Korea Peptic Ulcer Drugs Sales Market Share, 2015-2026
5.4 By Application - South Korea Peptic Ulcer Drugs Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Corporate Summary
6.1.2 Takeda Pharmaceutical Business Overview
6.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.1.4 Takeda Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.1.5 Takeda Pharmaceutical Key News
6.2 AstraZeneca
6.2.1 AstraZeneca Corporate Summary
6.2.2 AstraZeneca Business Overview
6.2.3 AstraZeneca Peptic Ulcer Drugs Major Product Offerings
6.2.4 AstraZeneca Sales and Revenue in South Korea (2015-2020)
6.2.5 AstraZeneca Key News
6.3 Pfizer
6.3.1 Pfizer Corporate Summary
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Peptic Ulcer Drugs Major Product Offerings
6.3.4 Pfizer Sales and Revenue in South Korea (2015-2020)
6.3.5 Pfizer Key News
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Corporate Summary
6.4.2 Teva Pharmaceuticals Business Overview
6.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Major Product Offerings
6.4.4 Teva Pharmaceuticals Sales and Revenue in South Korea (2015-2020)
6.4.5 Teva Pharmaceuticals Key News
6.5 EA Pharma
6.5.1 EA Pharma Corporate Summary
6.5.2 EA Pharma Business Overview
6.5.3 EA Pharma Peptic Ulcer Drugs Major Product Offerings
6.5.4 EA Pharma Sales and Revenue in South Korea (2015-2020)
6.5.5 EA Pharma Key News
6.6 ASK Pharm
6.6.1 ASK Pharm Corporate Summary
6.6.2 ASK Pharm Business Overview
6.6.3 ASK Pharm Peptic Ulcer Drugs Major Product Offerings
6.6.4 ASK Pharm Sales and Revenue in South Korea (2015-2020)
6.6.5 ASK Pharm Key News
6.7 Luoxin Pharmaceutical
6.6.1 Luoxin Pharmaceutical Corporate Summary
6.6.2 Luoxin Pharmaceutical Business Overview
6.6.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.4.4 Luoxin Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.7.5 Luoxin Pharmaceutical Key News
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Corporate Summary
6.8.2 Abbott Laboratories Business Overview
6.8.3 Abbott Laboratories Peptic Ulcer Drugs Major Product Offerings
6.8.4 Abbott Laboratories Sales and Revenue in South Korea (2015-2020)
6.8.5 Abbott Laboratories Key News
6.9 Yuhan Pharmaceutical
6.9.1 Yuhan Pharmaceutical Corporate Summary
6.9.2 Yuhan Pharmaceutical Business Overview
6.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.9.4 Yuhan Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.9.5 Yuhan Pharmaceutical Key News
6.10 Daewoong Pharmaceutical
6.10.1 Daewoong Pharmaceutical Corporate Summary
6.10.2 Daewoong Pharmaceutical Business Overview
6.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
6.10.4 Daewoong Pharmaceutical Sales and Revenue in South Korea (2015-2020)
6.10.5 Daewoong Pharmaceutical Key News
7 PEPTIC ULCER DRUGS PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Peptic Ulcer Drugs Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
7.1.1 South Korea Peptic Ulcer Drugs Production Capacity, 2015-2026
7.1.2 South Korea Peptic Ulcer Drugs Production 2015-2026
7.1.3 South Korea Peptic Ulcer Drugs Production Value 2015-2026
7.2 Key Local Peptic Ulcer Drugs Manufacturers in South Korea
7.2.1 South Korea Key Local Peptic Ulcer Drugs Manufacturers Production Capacity
7.2.2 South Korea Key Local Peptic Ulcer Drugs Manufacturers Production
7.2.3 South Korea Key Local Peptic Ulcer Drugs Manufacturers Production Value
7.2.4 The Proportion of Peptic Ulcer Drugs Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Peptic Ulcer Drugs Export and Import in South Korea
7.3.1 South Korea Peptic Ulcer Drugs Export Market
7.3.2 South Korea Peptic Ulcer Drugs Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for South Korea Peptic Ulcer Drugs Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON PEPTIC ULCER DRUGS SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Peptic Ulcer Drugs Distributors and Sales Agents in South Korea
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Peptic Ulcer Drugs in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Peptic Ulcer Drugs Revenue Share by Companies, 2015-2020
Table 5. South Korea Peptic Ulcer Drugs Sales by Companies, (M Unit), 2015-2020
Table 6. South Korea Peptic Ulcer Drugs Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Peptic Ulcer Drugs Price (2015-2020) (USD/K Units)
Table 8. South Korea Manufacturers Peptic Ulcer Drugs Product Type
Table 9. List of South Korea Tier 1 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Peptic Ulcer Drugs Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Peptic Ulcer Drugs Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Peptic Ulcer Drugs Sales in South Korea (M Unit), 2015-2020
Table 14. By Type - Peptic Ulcer Drugs Sales in South Korea (M Unit), 2021-2026
Table 15. By Application - Peptic Ulcer Drugs Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Peptic Ulcer Drugs Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Peptic Ulcer Drugs Sales in South Korea, (M Unit), 2015-2020
Table 18. By Application - Peptic Ulcer Drugs Sales in South Korea, (M Unit), 2021-2026
Table 19. Takeda Pharmaceutical Corporate Summary
Table 20. Takeda Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 21. Takeda Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 22. AstraZeneca Corporate Summary
Table 23. AstraZeneca Peptic Ulcer Drugs Product Offerings
Table 24. AstraZeneca Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 25. Pfizer Corporate Summary
Table 26. Pfizer Peptic Ulcer Drugs Product Offerings
Table 27. Pfizer Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 28. Teva Pharmaceuticals Corporate Summary
Table 29. Teva Pharmaceuticals Peptic Ulcer Drugs Product Offerings
Table 30. Teva Pharmaceuticals Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 31. EA Pharma Corporate Summary
Table 32. EA Pharma Peptic Ulcer Drugs Product Offerings
Table 33. EA Pharma Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 34. ASK Pharm Corporate Summary
Table 35. ASK Pharm Peptic Ulcer Drugs Product Offerings
Table 36. ASK Pharm Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 37. Luoxin Pharmaceutical Corporate Summary
Table 38. Luoxin Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 39. Luoxin Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 40. Abbott Laboratories Corporate Summary
Table 41. Abbott Laboratories Peptic Ulcer Drugs Product Offerings
Table 42. Abbott Laboratories Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 43. Yuhan Pharmaceutical Corporate Summary
Table 44. Yuhan Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 45. Yuhan Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 46. Daewoong Pharmaceutical Corporate Summary
Table 47. Daewoong Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 48. Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 49. Peptic Ulcer Drugs Production Capacity (M Unit) of Local Manufacturers in South Korea, 2015-2020
Table 50. Peptic Ulcer Drugs Production (M Unit) of Local Manufacturers in South Korea, 2015-2020
Table 51. South Korea Peptic Ulcer Drugs Production Market Share of Local Manufacturers, 2015-2020
Table 52. Peptic Ulcer Drugs Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 53. South Korea Peptic Ulcer Drugs Production Value Market Share of Local Manufacturers, 2015-2020
Table 54. The Percentage of Peptic Ulcer Drugs Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 55. The Percentage of Peptic Ulcer Drugs Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 56. Dangeguojia Peptic Ulcer Drugs Sales (Consumption), Production, Export and Import, 2015-2020
Table 57. Raw Materials and Suppliers
Table 58. Peptic Ulcer Drugs Downstream Clients in South Korea
Table 59. Peptic Ulcer Drugs Distributors and Sales Agents in South Korea
Table 1. Key Players of Peptic Ulcer Drugs in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Peptic Ulcer Drugs Revenue Share by Companies, 2015-2020
Table 5. South Korea Peptic Ulcer Drugs Sales by Companies, (M Unit), 2015-2020
Table 6. South Korea Peptic Ulcer Drugs Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Peptic Ulcer Drugs Price (2015-2020) (USD/K Units)
Table 8. South Korea Manufacturers Peptic Ulcer Drugs Product Type
Table 9. List of South Korea Tier 1 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Peptic Ulcer Drugs Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Peptic Ulcer Drugs Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Peptic Ulcer Drugs Sales in South Korea (M Unit), 2015-2020
Table 14. By Type - Peptic Ulcer Drugs Sales in South Korea (M Unit), 2021-2026
Table 15. By Application - Peptic Ulcer Drugs Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Peptic Ulcer Drugs Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Peptic Ulcer Drugs Sales in South Korea, (M Unit), 2015-2020
Table 18. By Application - Peptic Ulcer Drugs Sales in South Korea, (M Unit), 2021-2026
Table 19. Takeda Pharmaceutical Corporate Summary
Table 20. Takeda Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 21. Takeda Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 22. AstraZeneca Corporate Summary
Table 23. AstraZeneca Peptic Ulcer Drugs Product Offerings
Table 24. AstraZeneca Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 25. Pfizer Corporate Summary
Table 26. Pfizer Peptic Ulcer Drugs Product Offerings
Table 27. Pfizer Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 28. Teva Pharmaceuticals Corporate Summary
Table 29. Teva Pharmaceuticals Peptic Ulcer Drugs Product Offerings
Table 30. Teva Pharmaceuticals Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 31. EA Pharma Corporate Summary
Table 32. EA Pharma Peptic Ulcer Drugs Product Offerings
Table 33. EA Pharma Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 34. ASK Pharm Corporate Summary
Table 35. ASK Pharm Peptic Ulcer Drugs Product Offerings
Table 36. ASK Pharm Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 37. Luoxin Pharmaceutical Corporate Summary
Table 38. Luoxin Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 39. Luoxin Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 40. Abbott Laboratories Corporate Summary
Table 41. Abbott Laboratories Peptic Ulcer Drugs Product Offerings
Table 42. Abbott Laboratories Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 43. Yuhan Pharmaceutical Corporate Summary
Table 44. Yuhan Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 45. Yuhan Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 46. Daewoong Pharmaceutical Corporate Summary
Table 47. Daewoong Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 48. Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)
Table 49. Peptic Ulcer Drugs Production Capacity (M Unit) of Local Manufacturers in South Korea, 2015-2020
Table 50. Peptic Ulcer Drugs Production (M Unit) of Local Manufacturers in South Korea, 2015-2020
Table 51. South Korea Peptic Ulcer Drugs Production Market Share of Local Manufacturers, 2015-2020
Table 52. Peptic Ulcer Drugs Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 53. South Korea Peptic Ulcer Drugs Production Value Market Share of Local Manufacturers, 2015-2020
Table 54. The Percentage of Peptic Ulcer Drugs Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 55. The Percentage of Peptic Ulcer Drugs Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 56. Dangeguojia Peptic Ulcer Drugs Sales (Consumption), Production, Export and Import, 2015-2020
Table 57. Raw Materials and Suppliers
Table 58. Peptic Ulcer Drugs Downstream Clients in South Korea
Table 59. Peptic Ulcer Drugs Distributors and Sales Agents in South Korea
LIST OF FIGURES
Figure 1. Peptic Ulcer Drugs Segment by Type
Figure 2. Peptic Ulcer Drugs Segment by Application
Figure 3. Dangeguojia Peptic Ulcer Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Peptic Ulcer Drugs Market Size in South Korea, (US$, Mn) & (M Unit): 2020 VS 2026
Figure 6. South Korea Peptic Ulcer Drugs Revenue, 2015-2026 (US$, Mn)
Figure 7. Peptic Ulcer Drugs Sales in South Korea: 2015-2026 (M Unit)
Figure 8. The Top 3 and 5 Players Market Share by Peptic Ulcer Drugs Revenue in 2019
Figure 9. By Type - South Korea Peptic Ulcer Drugs Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Peptic Ulcer Drugs Market Share, 2015-2020
Figure 11. By Type - South Korea Peptic Ulcer Drugs Market Share, 2020-2026
Figure 12. By Type - South Korea Peptic Ulcer Drugs Price (USD/K Units), 2015-2026
Figure 13. By Application - Peptic Ulcer Drugs Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Peptic Ulcer Drugs Market Share, 2015-2020
Figure 15. By Application - South Korea Peptic Ulcer Drugs Market Share, 2020-2026
Figure 16. By Application -South Korea Peptic Ulcer Drugs Price (USD/K Units), 2015-2026
Figure 17. South Korea Peptic Ulcer Drugs Production Capacity (M Unit), 2015-2026
Figure 18. South Korea Peptic Ulcer Drugs Actual Output (M Unit), 2015-2026
Figure 19. South Korea Peptic Ulcer Drugs Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Peptic Ulcer Drugs Export Destination, 2019
Figure 21. The Source of Imports of South Korea Peptic Ulcer Drugs, 2019
Figure 22. PEST Analysis for South Korea Peptic Ulcer Drugs Market in 2020
Figure 23. Peptic Ulcer Drugs Market Opportunities & Trends in South Korea
Figure 24. Peptic Ulcer Drugs Market Drivers in South Korea
Figure 25. Peptic Ulcer Drugs Market Restraints in South Korea
Figure 26. Peptic Ulcer Drugs Industry Value Chain
Figure 1. Peptic Ulcer Drugs Segment by Type
Figure 2. Peptic Ulcer Drugs Segment by Application
Figure 3. Dangeguojia Peptic Ulcer Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Peptic Ulcer Drugs Market Size in South Korea, (US$, Mn) & (M Unit): 2020 VS 2026
Figure 6. South Korea Peptic Ulcer Drugs Revenue, 2015-2026 (US$, Mn)
Figure 7. Peptic Ulcer Drugs Sales in South Korea: 2015-2026 (M Unit)
Figure 8. The Top 3 and 5 Players Market Share by Peptic Ulcer Drugs Revenue in 2019
Figure 9. By Type - South Korea Peptic Ulcer Drugs Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Peptic Ulcer Drugs Market Share, 2015-2020
Figure 11. By Type - South Korea Peptic Ulcer Drugs Market Share, 2020-2026
Figure 12. By Type - South Korea Peptic Ulcer Drugs Price (USD/K Units), 2015-2026
Figure 13. By Application - Peptic Ulcer Drugs Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Peptic Ulcer Drugs Market Share, 2015-2020
Figure 15. By Application - South Korea Peptic Ulcer Drugs Market Share, 2020-2026
Figure 16. By Application -South Korea Peptic Ulcer Drugs Price (USD/K Units), 2015-2026
Figure 17. South Korea Peptic Ulcer Drugs Production Capacity (M Unit), 2015-2026
Figure 18. South Korea Peptic Ulcer Drugs Actual Output (M Unit), 2015-2026
Figure 19. South Korea Peptic Ulcer Drugs Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Peptic Ulcer Drugs Export Destination, 2019
Figure 21. The Source of Imports of South Korea Peptic Ulcer Drugs, 2019
Figure 22. PEST Analysis for South Korea Peptic Ulcer Drugs Market in 2020
Figure 23. Peptic Ulcer Drugs Market Opportunities & Trends in South Korea
Figure 24. Peptic Ulcer Drugs Market Drivers in South Korea
Figure 25. Peptic Ulcer Drugs Market Restraints in South Korea
Figure 26. Peptic Ulcer Drugs Industry Value Chain
